More hope on Liver Cirrhosis front.


Vesta Therapeutics will research use of adult stem cells as a possible treatment for liver disease with funding from the National Institutes of Health.

The phase 1 small business innovation research grant was awarded by the National Institutes of Diabetes and Digestive and Kidney Diseases, a division of NIH.

The amount of the grant was not disclosed.

Vesta hopes to develop an alternative treatment to liver transplants for liver diseases such as hepatitis and cirrhosis.

“A number of studies have demonstrated that adult stem cells from multiple tissues can improve in vivo regeneration of damaged organs, including the liver,” Vesta said in a statement.

Link


  • Stem cell hope for liver cirrhosis
  • Stem Cell Can be Used to Repair Damaged Human Livers
  • Stem Cell Provides Hope for Liver Failure
  • California Receives Grants Of $24 Million For Stem Cell Research In The State
  • Stem Cell Therapeutics Corp receives permission from Health Canada for first ever brain injury trial
  • Stanford Receives 1.2 Million For Stem Cell Research
  • Stem Cells Can Make Liver Transplantations Obsolete
  • Scientists Have Grown World's First Artificial Liver From Stem Cells
  • Public Cord Blood Bank in Texas Awarded 1.2 Million State Grant
  • Stem Cell Lines Developed For Bioartificial Liver Device By HepaLife